• Chlordiazepoxide, Serum
  • Culture, Acid-Fast Bacilli, Sputum
  • Salivary Gland Tumor, MYB (6q23) Rearrangement by FISH
  • Eosinophils, Urine
  • Interferon-γ Receptor (IFNGR1) Deficiency
  • Ropivacaine, Serum
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Serine and Arginine-rich Splicing Factor 2 (SRSF2) Gene Mutation Analysis
  • Coagulation Factor II Activity Assay, Plasma
  • Diabetes insipidus
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Peritoneal Fluid
Medical Test

Turnaround Time
Access to Cancer Antigen (CA) 19-9, Peritoneal Fluid is restricted.